Evidence map›Paper›PMID 30873006›Full record

ArticleFrontiers in cellular neuroscience2019

Silencing of lncRNA PKIA-AS1 Attenuates Spinal Nerve Ligation-Induced Neuropathic Pain Through Epigenetic Downregulation of CDK6 Expression.

Jian-Zhong Hu, Zi-Jie Rong, Miao Li, Ping Li, Li-Yuan Jiang, Zi-Xiang Luo, Chun-Yue Duan, Yong Cao, Hong-Bin Lu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Non-coding RNAs in neuropathic pain.Neuronal signaling · 2020
    Review
  17. Article
  18. The Emerging Role of lncRNAs in Spinal Cord Injury.BioMed research international · 2019
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jian-Zhong HuDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Zi-Jie RongDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Miao LiDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Ping LiDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Li-Yuan JiangDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Zi-Xiang LuoDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Chun-Yue DuanDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Yong CaoDepartment of Spine Surgery, Xiangya Hospital, Central South University, Changsha, China.
Hong-Bin LuKey Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, Xiangya Hospital, Central South University, Changsha, China.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathic pain (NP) is among the most intractable comorbidities of spinal cord injury. Dysregulation of non-coding RNAs has also been implicated in the development of neuropathic pain. Here, we identified a novel lncRNA, PKIA-AS1, by using lncRNA array analysis in spinal cord tissue of spinal nerve ligation (SNL) model rats, and investigated the role of PKIA-AS1 in SNL-mediated neuropathic pain. We observed that PKIA-AS1 was significantly upregulated in SNL model rats and that PKIA-AS1 knockdown attenuated neuropathic pain progression. Alternatively, overexpression of PKIA-AS1 was sufficient to induce neuropathic pain-like symptoms in uninjured rats. We also found that PKIA-AS1 mediated SNL-induced neuropathic pain by directly regulating the expression and function of CDK6, which is essential for the initiation and maintenance of neuroinflammation and neuropathic pain. Therefore, our study identifies PKIA-AS1 as a novel therapeutic target for neuroinflammation related neuropathic pain.

Indexed as

CDK6long non-coding RNAneuroinflammationneuropathic painspinal cord injury

Identifiers

PMID30873006
PMCPMC6401634
OpenAlexW2915905680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.